Lava Therapeutics Nv Share Price Today
(NASDAQ: LVTX)

Name: Lava Therapeutics Nv Share Price Today (NASDAQ: LVTX) - Lava Therapeutics Nv Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Lava Therapeutics Nv share price is $1.24 & ₹104.94 as on 2 May 2025, 2.30 'hrs' IST

$1.24

▲

-0.01

(-0.8%)

Market is closed - opens 7 PM, 02 May 2025

View live Lava Therapeutics Nv share price in Dollar and Rupees. Guide to invest in Lava Therapeutics Nv stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Lava Therapeutics Nv, along with analyst recommendations, forecasts, and comprehensive financials.

Lava Therapeutics Nv share price movements

Today's Low: $1.22
Today's High: $1.28
$1.24
1.61%
Downside
Day's Volatility :4.69%
Upside
3.13%
52 Weeks Low: $0.85
52 Weeks High: $3.20
$1.24
31.44%
Downside
52 Weeks Volatility :73.43%
Upside
61.25%

Lava Therapeutics Nv (LVTX) Returns

Period	Lava Therapeutics Nv	Sector (Health Care)	Index (Russel 2000)
3 Months	24.49%	-4.4%	0.0%
6 Months	-35.26%	-5.0%	0.0%
1 Year	-60.65%	-0.1%	0.0%
3 Years	-68.9%	8.4%	-6.1%

Lava Therapeutics Nv (LVTX) Key Statistics

in dollars & INR

Previous Close	$1.25
Open	$1.239
Today's High	$1.28
Today's Low	$1.22
Market Capitalization	$33.1M
Today's Volume	$73.1K
52 Week High	$3.2
52 Week Low	$0.8502
Revenue TTM	$12.0M
EBITDA	$-25.3M
Earnings Per Share (EPS)	$-0.94
Profit Margin	-209.6%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-63.49%

How to invest in Lava Therapeutics Nv Stock (LVTX) from India?

It is very easy for Indian residents to invest directly in Lava Therapeutics Nv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lava Therapeutics Nv stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lava Therapeutics Nv or LVTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lava Therapeutics Nv or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lava Therapeutics Nv shares which would translate to 0.682 fractional shares of Lava Therapeutics Nv as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lava Therapeutics Nv, in just a few clicks!

Returns in Lava Therapeutics Nv (LVTX) for Indian investors in Rupees

The Lava Therapeutics Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Lava Therapeutics Nv investment value today

Current value as on today

₹41,417

Returns

₹58,583

(-58.58%)

Returns from Lava Therapeutics Nv Stock

₹60,000 (-60%)

Dollar Returns

₹1,417 (+1.42%)

Indian investors sentiment towards Lava Therapeutics Nv (LVTX)

-33%

Period: Apr 1, 2025 to May 1, 2025. Change in 30 Days versus previous period

Search interest for Lava Therapeutics Nv Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Lava Therapeutics Nv

Redmile Group, LLC
7.89%
Sanofi
7.30%
Merck & Co Inc
4.37%
Bruce & Co Inc
2.93%
Sphera Funds Management Ltd.
0.48%
Pathway Financial Advisors LLC
0.39%

Analyst Recommendation on Lava Therapeutics Nv

Rating

Trend

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Lava Therapeutics Nv(by analysts ranked 0 to 5 stars)

Analyst Forecast on Lava Therapeutics Nv Stock (LVTX)

What analysts predicted

Upside of 55.64%

Target:

$1.93

Current:

$1.24

Insights on Lava Therapeutics Nv Stock (Ticker Symbol: LVTX)

Price Movement
In the last 7 days, LVTX stock has moved down by -6.1%
Increasing Revenue
Revenue is up for the last 2 quarters, 227.99K → 4.99M (in $), with an average increase of 95.4% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -12.29M → -3.97M (in $), with an average increase of 209.7% per quarter
LVTX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.1% return, outperforming this stock by 135.4%
LVTX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 89.3% return, outperforming this stock by 157.6%
Price to Sales
ForLVTX every $1 of sales, investors are willing to pay $2.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.5 for every $1 of sales.

Lava Therapeutics Nv Technicals Summary

Sell

Neutral

Buy

Lava Therapeutics Nv is currently in a neutral trading position according to technical analysis indicators.

Lava Therapeutics Nv (LVTX) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Lava Therapeutics Nv	-3.94%	-35.26%	-60.65%	-68.9%	-91.47%
Biontech Se	9.85%	-8.05%	11.13%	-31.31%	123.92%
Regeneron Pharmaceuticals, Inc.	-4.3%	-29.03%	-36.14%	-9.35%	10.5%
Vertex Pharmaceuticals Incorporated	5.32%	8.08%	27.25%	89.22%	92.38%
Alnylam Pharmaceuticals, Inc.	-1.34%	-3.89%	75.14%	84.24%	92.68%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Lava Therapeutics Nv	0.25	NA	NA	-1.44	-0.63	-0.18	NA	1.06
Biontech Se	160.8	NA	0.04	-5.11	-0.03	-0.04	NA	80.89
Regeneron Pharmaceuticals, Inc.	15.94	15.94	0.96	39.38	0.16	0.07	0.01	273.57
Vertex Pharmaceuticals Incorporated	32.84	NA	1.38	17.94	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.72	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Lava Therapeutics Nv	Buy	$33.1M	-91.47%	0.25	-209.6%
Biontech Se	Buy	$29.5B	123.92%	160.8	-24.18%
Regeneron Pharmaceuticals, Inc.	Buy	$66.5B	10.5%	15.94	31.07%
Vertex Pharmaceuticals Incorporated	Buy	$129.4B	92.38%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.3B	92.68%	NA	-12.37%

About Lava Therapeutics Nv

LAVA Therapeutics N.V. operates as a clinical-stage immuno-oncology company that focuses on developing cancer treatments. The company through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is developing other Gammabody drug candidates, which include LAVA-1223, which targets the epidermal growth factor receptor (EGFR) for the treatment of selected solid tumors, as well as LAVA-1266 which are preclinical candidates for the treatment of various hematologic malignancies. The company has a research collaboration and license agreement with Janssen Biotech, Inc. for the potential discovery and development of multi-specific antibody products that are directed to a specified target in various fields of use; and a collaboration with Merck & Co., Inc. to evaluate anti-PD-1 therapy KEYTRUDA in combination with LAVA-1207. LAVA Therapeutics N.V. was incorporated in 2016 and is based in Utrecht, the Netherlands.

Organization	Lava Therapeutics Nv
Employees	34
CEO	Mr. Stephen Allen Hurly M.B.A., M.Sc.
Industry	Services

Management People of Lava Therapeutics Nv

Name	Title
Mr. Stephen Allen Hurly M.B.A., M.Sc.	CEO, President & Executive Director
Mr. Fred M. Powell CPA	Chief Financial Officer
Ms. Oxana Polyakova Ph.D.	Chief Scientific Officer
Ms. Amy Garabedian J.D.	General Counsel & Corporate Secretary
Mr. Wouter van Hunnik	VP & Head of Human Resources
Dr. Hans van der Vliet M.D., Ph.D.	Head of Innovation
Dr. Ton Adang Ph.D.	Chief Development Officer
Dr. Charles Q. Morris M.D., MBChB, MRCP (UK), Ph.D.	Chief Medical Officer

Important FAQs about investing in LVTX Stock from India :

What is Lava Therapeutics Nv share price today?

Lava Therapeutics Nv share price today stands at $1.24, Open: $1.24 ; Previous Close: $1.25 ; High: $1.28 ; Low: $1.22 ; 52 Week High: $3.20 ; 52 Week Low: $0.85.

The stock opens at $1.24, after a previous close of $1.25. The stock reached a daily high of $1.28 and a low of $1.22, with a 52-week high of $3.20 and a 52-week low of $0.85.

Can Indians buy Lava Therapeutics Nv shares?

Yes, Indians can invest in the Lava Therapeutics Nv (LVTX) from India.

With INDmoney, you can buy Lava Therapeutics Nv at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Lava Therapeutics Nv at zero transaction cost.

How can I buy Lava Therapeutics Nv shares from India?

It is very easy to buy Lava Therapeutics Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lava Therapeutics Nv (LVTX) be purchased?

Yes, you can buy fractional shares of Lava Therapeutics Nv with INDmoney app.

What are the documents required to start investing in Lava Therapeutics Nv stocks?

To start investing in Lava Therapeutics Nv, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.